These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 19811503

  • 1. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
    Brandes JL, Poole Ac, Kallela M, Schreiber CP, MacGregor EA, Silberstein SD, Tobin J, Shaw R.
    Cephalalgia; 2009 Nov; 29(11):1133-48. PubMed ID: 19811503
    [Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH, Jones MW.
    Headache; 2007 Feb; 47(7):1037-49. PubMed ID: 17635595
    [Abstract] [Full Text] [Related]

  • 10. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
    Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW.
    J Womens Health (Larchmt); 2014 Apr; 23(4):310-7. PubMed ID: 24450487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
    Spierings EL, Keywood C.
    Pain Med; 2009 Jul; 10(4):633-8. PubMed ID: 19453958
    [Abstract] [Full Text] [Related]

  • 18. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.